Adverse drug reactions (ADRs) are considered among important causes of morbidity and mortality. In order to minimize the harmful effects of medicines, countries have developed their own pharmacovigilance mechanisms. Yemen is a developing country located in Southern West of Asia which launched its own national pharmacovigilance program. The current pharmacovigilance program started with a limited activities implemented over a restricted area of the country and received only limited ADR reports. Though the program is successful to a certain extend, still there is a scope for improvement. This review addressed the drug regulation in Yemen, including the implementations and limitations of these regulation, highlighting the need for pharmacovigilance and go throughout the different stages of pharmacovigilance activities in Yemen and, finally suggesting measures and steps to foster pharmacovigilance activities to achieve the desired health care outcomes in Yemen.
Safety Monitoring of Medicines: The Available Mechanism in Yemen
Mohammed Ahmed Alshakka1*, Sana S. Al- Kubati1 , Heyam Ali2 , Mustafa Alshagga3
1Department of Clinical Pharmacy, Faculty of Pharmacy, Aden University, Yemen 2Department of Pharmaceutics, Dubai Pharmacy College, Dubai, UAE 3School of Biomedical Sciences, Faculty of Science, University of Nottingham Malaysia Campus, Semenyih, Malaysia